Literature DB >> 19685027

Secondary neoplasms after Wilms' tumor in Germany.

Nasenien Nourkami1, Rhoikos Furtwängler, Muhannad Alkassar, Norbert Graf.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19685027     DOI: 10.1007/s00066-009-1006-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  14 in total

1.  Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.

Authors:  J de Kraker; N Graf; H van Tinteren; F Pein; B Sandstedt; J Godzinski; M F Tournade
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

2.  Success of clinical trials in childhood Wilms' tumour around the world.

Authors:  K Pritchard-Jones; J Pritchard
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

3.  [Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study].

Authors:  Tobias Bölling; Andreas Schuck; Christian Rübe; Stefan Hesselmann; Hildegard Pape; Karin Dieckmann; Barbara Pöllinger; Rolf-Dieter Kortmann; Irene Speiser-Held; Frank-Michael Meyer; Carmen Martini; Branka Asadpour; Beate Timmermann; Jörn D Beck; Thorsten Langer; Marios Paulides; Bernhard Schmidt; Normann Willich
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

4.  Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.

Authors:  M F Tournade; C Com-Nougué; J de Kraker; R Ludwig; A Rey; J M Burgers; B Sandstedt; J Godzinski; M Carli; R Potter; J M Zucker
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

5.  [Wilms' tumor - update 2007].

Authors:  H Reinhard; R Furtwängler; N Graf
Journal:  Urologe A       Date:  2007-02       Impact factor: 0.639

Review 6.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

7.  Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH.

Authors:  M Marx; T Langer; N Graf; G Hausdorf; W Stöhr; R Ludwig; J D Beck
Journal:  Med Pediatr Oncol       Date:  2002-07

8.  Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies.

Authors:  Harald Reinhard; Andrea Schmidt; Rhoikos Furtwängler; Ivo Leuschner; Christian Rübe; Dietrich Von Schweinitz; Andreas Zoubek; Felix Niggli; Norbert Graf
Journal:  Oncol Rep       Date:  2008-08       Impact factor: 3.906

9.  Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study.

Authors:  Aliki J Taylor; David L Winter; Kathy Pritchard-Jones; Charles A Stiller; Clare Frobisher; Emma R Lancashire; Raoul C Reulen; Mike M Hawkins
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

Review 10.  Second tumors after oncologic treatment.

Authors:  Wolfgang Dörr; Thomas Herrmann
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621

View more
  1 in total

Review 1.  [Surgical concepts in the treatment of Wilms tumor: An update].

Authors:  J Fuchs
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.